Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4kin | 1M8 | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.572 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.554 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.554 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.548 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.546 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.545 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.538 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.538 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.535 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.534 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.534 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.529 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.515 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.513 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.511 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.508 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.498 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.488 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 2gtn | LIE | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.486 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.485 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.482 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.476 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.475 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.472 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.471 | |
| 3ehe | NAD | UDP-glucose 4-epimerase (GalE-1) | / | 0.470 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.470 | |
| 3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 3bv2 | P38 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 3ggp | NAD | Prephenate dehydrogenase | / | 0.467 | |
| 3r5z | F42 | Uncharacterized protein | / | 0.467 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.465 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.464 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.463 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.461 | |
| 2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.461 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.460 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.459 | |
| 1bim | 0QB | Renin | 3.4.23.15 | 0.458 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.458 | |
| 3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.458 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.458 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.458 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.458 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.457 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.457 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.457 | |
| 3hja | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.457 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.455 | |
| 4y8w | STR | Steroid 21-hydroxylase | / | 0.455 | |
| 1g1a | NAD | dTDP-glucose 4,6-dehydratase | / | 0.454 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.454 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 4uyf | 73B | Bromodomain-containing protein 2 | / | 0.453 | |
| 2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.452 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
| 3bg7 | FAD | Pyranose 2-oxidase | / | 0.452 | |
| 3mpj | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.452 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.451 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.451 | |
| 3nxx | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
| 4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.451 | |
| 1ie4 | T44 | Transthyretin | / | 0.450 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.449 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.449 | |
| 3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
| 3iae | D7K | Benzaldehyde lyase | / | 0.449 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.449 | |
| 1e3e | NAI | Alcohol dehydrogenase 4 | 1.1.1.1 | 0.448 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.448 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3bhi | NAP | Carbonyl reductase [NADPH] 1 | 1.1.1.184 | 0.448 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
| 4jx1 | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
| 5d3q | GDP | Dynamin-1 | 3.6.5.5 | 0.448 | |
| 1ie3 | NAD | Malate dehydrogenase | / | 0.447 | |
| 2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.447 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
| 3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.447 | |
| 3k4n | FAD | Pyranose 2-oxidase | / | 0.447 | |
| 4h8a | NAI | Ureidoglycolate dehydrogenase (NAD(+)) | 1.1.1.350 | 0.447 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.447 | |
| 3b70 | NAP | Enoyl reductase LovC | 1 | 0.446 | |
| 3lsh | FAD | Pyranose 2-oxidase | / | 0.446 | |
| 3w0h | W12 | Vitamin D3 receptor | / | 0.446 | |
| 3znp | FAD | D-amino-acid oxidase | 1.4.3.3 | 0.446 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.445 | |
| 1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.445 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 2ooy | ATP | 5'-AMP-activated protein kinase subunit gamma | / | 0.445 | |
| 3drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 3gqv | NAP | Enoyl reductase LovC | 1 | 0.445 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
| 3sz0 | FAD | Sulfide-quinone reductase | / | 0.445 | |
| 4e5y | NDP | GDP-L-fucose synthase | 1.1.1.271 | 0.445 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.445 | |
| 4xgi | NAD | Glutamate dehydrogenase | / | 0.445 | |
| 1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.444 | |
| 1qvn | FRI | Interleukin-2 | / | 0.444 | |
| 2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.444 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.444 | |
| 3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.444 | |
| 3il1 | B5D | Glutamate receptor 2 | / | 0.444 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.444 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
| 4oxy | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.444 | |
| 1ida | 0PO | Gag-Pol polyprotein | 3.4.23.47 | 0.443 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.443 | |
| 2dte | NAI | Glucose 1-dehydrogenase related protein | / | 0.443 | |
| 2fzw | NAD | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.443 | |
| 3kpk | FAD | Sulfide-quinone reductase | / | 0.443 | |
| 3syi | FAD | Sulfide-quinone reductase | / | 0.443 | |
| 3t2y | FAD | Sulfide-quinone reductase | / | 0.443 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
| 4ejm | NAP | Putative zinc-binding dehydrogenase | / | 0.443 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.443 | |
| 3hwr | NDP | 2-dehydropantoate 2-reductase | / | 0.442 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.441 | |
| 2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.441 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.441 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
| 2vyn | NAD | Glyceraldehyde-3-phosphate dehydrogenase A | / | 0.441 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3lsi | FAD | Pyranose 2-oxidase | / | 0.441 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.441 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
| 1c1d | NAI | Phenylalanine dehydrogenase | / | 0.440 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 1tdf | FAD | Thioredoxin reductase | 1.8.1.9 | 0.440 | |
| 2rbe | NDP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
| 2y8q | ADP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.440 | |
| 3r83 | Z14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.440 | |
| 4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 | |
| 4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.440 | |
| 4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.440 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 4m87 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.440 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 |